

Difficulties in diagnosing moyamoya disease
https://doi.org/10.21508/1027-4065-2023-68-5-102-109
Abstract
Moyamoya disease is a progressive cerebrovascular disease characterized by bilateral stenosis of the supraclinoid (proximal) part of the internal carotid arteries and the initial segments of the anterior and middle cerebral arteries, with subsequent involvement of the vertebrobasilar basin and accompanied by the development of a basal network of anastomoses. The disease most often manifests itself at the age of 5 to 30–40 years, which makes this pathology an actual and significant cause of functional disorders in children and young people. Diagnosis of moyamoya disease can be difficult because of the polymorphism of its clinical manifestations. This disease must be taken into account in the differential diagnosis of symptoms of cerebral ischemia, since early detection and therapeutic intervention can improve the prognosis by preventing irreversible brain damage. The article presents its own clinical observation of a 6-year-old child with moyamoya disease with a predominant lesion of the right internal carotid artery basin.
About the Authors
Yu. S. MelnikovaRussian Federation
Kazan
D. I. Sadykova
Russian Federation
Kazan
T. P. Makarova
Russian Federation
Kazan
D. M. Yasav
Russian Federation
Kazan
A. F. Khamidullin
Russian Federation
Kazan
M. F. Bikmullin
Russian Federation
Kazan
References
1. Kovalenko A.P., Shopin V.N., Penner V.A., Shcherbin A.V. MoyaМoya disease: a case from practice. Ukraїns’ka іnterventsіina neiroradіologіya ta khіrurgіya 2013; 3(5): 54–61. (in Russ.)
2. Shulgina A.A., Lukshin V.A., Usachev D.Yu., Korshunov A.E., Belousova O.B., Pronin I.N. Combined revascularization of the brain in the treatment of Moya-Мoya disease. Zhurnal «Voprosy nejrohirurgii» imeni N.N. Burdenko 2021; 85(2): 47–59. (in Russ.) DOI: 10.17116/neiro20218502147
3. Kuzmenko S.G., Ponomarev V.V., Rimashevsky V.B., Derkacheva N.V. Clinical and neuroimaging suspicions in Moya-Мoya disease. Mezhdunarodnyi nevrologicheskii zhurnal 2017; 3(89): 130–135. (in Russ.)
4. Mineharu Y., Liu W., Inoue K., Ma tsuura N., Inoue S., Takenaka K. et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 2008; 70(24):357–363. DOI: 10.1212/01.wnl.000029 1012.49986.f9
5. Kamada F., Aoki Y., Narisawa A., Abe Y., Komatsuzaki S., Kikuchi A. et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Geneti 2011; 56(1): 34–40. DOI: 10.1038/jhg.2010.132
6. Fujimura M., Sonobe S., Nishijima Y., Niizuma K., Sakata H., Kure S., Tominaga T. Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene. J Stroke 2014; 16(2): 65–72. DOI: 0.5853/jos.2014.16.2.65
7. Ponomarev V.V., Yudina O.A. Moya-Мoya disease: clinical and pathomorphological cases. Mezhdunarodnyi nevrologicheskii zhurnal 2008; 4(20). (in Russ.)
8. Yamada M., Fujii K., Fukui M. Clinical features and outcomes in patients with asymptomatic moyamoya disease — from the results of nation-wide questionnaire survey. No To Shinkei: Brain and Nerve 2005; 33(4): 337–342
9. Kuroda S. AMORE Study Group. Asymptomatic moyamoya disease: literature review and ongoing AMORE study. Neurologia Medico-Chirurgica 2015; 55(3): 194–198. DOI: 10.2176/nmc.ra.2014–0305
10. Kuroda S., Hashimoto N., Yoshimoto T., Iwasaki Y. Research Committee on Moyamoya Disease in Japan. Radiological Findings, Clinical Course, and Outcome in Asymptomatic Moyamoya Disease. Stroke 2007; 38(5): 1430–1435. DOI: 10.1161/STROKEAHA.106.478297
11. Garg B.P., Bruno A., Biller J. Moyamoya disease and cerebral ischemia. In: Cerebrovascular Disease. Editor Batjer H.H. Philadelphia: Lippincott-Raven Publishers, 1997: 489–499
12. Scott R.M., Smith E.R. Moyamoya disease and moyamoya syndrome. New Engl J Med 2009; 360(12): 1226–1237. DOI: 10.1056/NEJMra0804622
13. Shulgina A.A., Lukshin V.A., Korshunov A.E., Belousova O.B., Pronin I.N., Usachev D.Yu. Modern trends in the diagnosis and surgical treatment of Moya-Мoya disease. ZHurnal «Voprosy nejrohirurgii» imeni N.N. Burdenko 2020; 84(4): 90–103. (in Russ.) DOI: 10.17116/neiro20208404190
14. Kuroda S., Ishikawa T., Houkin K., Nanba R., Hokari M., Iwasaki Y. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 2005; 36(10): 2148–2153. DOI: 10.1161/01.STR.0000182256.32489.99
15. Kurlemann G., Fahrendorf G., Krings W., Sciuk J., Palm D. Characteristic EEG findings in childhood moyamoya syndrome. Neurosurg Rev 1992; 15(1): 57–60. DOI: 10.1007/bf02352069
16. Lee M., Zaharchuk G., Guzman R., Achrol A., Bell- Stephens T., Steinberg G.K. Quantitative hemodynamic studies in moyamoya disease: a review. Neurosurg Focus 2009; 26(4): E5. DOI: 10.3171/2009.1.FOCUS08300
17. Guzman R., Lee M., Achrol A., Bell-Stephens T., Kelly M., Do H.M. et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 2009; 111(5): 927–935. DOI: 10.3171/2009.4.JNS081649
18. Miyamoto S., Yoshimoto T., Hashimoto N., Okada Y., Tsuji I., Tominaga T. et al. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke 2014; 45(5): 1415–1421. DOI: 10.1161/STROKEAHA.113.004386
19. Luo R., Gao F., Deng X., Zhang D., Zhang Y. Results of Conservative Followup or Surgical Treatment of Moyamoya Patients Who Present without Hemorrhage, Transient Ischemic Attack, or Stroke. World Neurosurg 2017; 108: 683–689. DOI: 10.1016/j.wneu.2017.09.056
Review
For citations:
Melnikova Yu.S., Sadykova D.I., Makarova T.P., Yasav D.M., Khamidullin A.F., Bikmullin M.F. Difficulties in diagnosing moyamoya disease. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2023;68(5):102-109. (In Russ.) https://doi.org/10.21508/1027-4065-2023-68-5-102-109